PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human LIF (Animal-Free), 25 μg
Recombinant Human LIF (carrier-free) , 10 μg
Recombinant Human LIF (carrier-free) , 100 μg
Recombinant Human LIF (carrier-free) , 25 μg
Recombinant Human LIF (carrier-free) , 500 μg
Recombinant Human Light (TNFSF14) (carrier-free), 10 µg
Recombinant Human Light (TNFSF14) (carrier-free), 15 µg
Recombinant Human Light (TNFSF14) (carrier-free), 25 µg
Recombinant Human Light (TNFSF14) (carrier-free), 3 µg
Recombinant Human LT-α (TNF-β), 20 μg
Recombinant Human LT-α (TNF-β), 5 μg
Recombinant Human MCP-1/CCL2 (ELISA Std.), 4 pack
Recombinant Human M-CSF (Animal-Free), 10 μg
Recombinant Human M-CSF (carrier-free), 10 μg
Recombinant Human M-CSF (carrier-free), 100 μg
Recombinant Human M-CSF (carrier-free), 25 μg